Shirong Li

1PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 03, 2018
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation.

Shirong Li, Jing Fu, Hui Wang

Pageof 1

Frequent Collaborators

1 joint publications

Jing Fu

1 joint publications

Suzanne Lentzsch